Skip to main content
OXY $58.36 +1.14%
OXY logo

OXY · Occidental Petroleum Corp /De/

Track OXY — free
$58.36 +0.66 (+1.14%) At close · Aug 14
Market Cap
$58.53B
Shares
999.64M
All earnings calls

Earnings call · FY2025 Q4

Occidental Petroleum Corp /De/ Q4 FY2025 Earnings Call

Occidental Petroleum Corp /De/ Q4 FY2025 Earnings Call

Concluded Feb 18, 2026 Audio replay
Feb 18, 2026 1:02:11 36 turns
Period
FY2025 Q4
Runtime
1:02:11
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Occidental delivered record 2025 production of 1.434 MMboe/d and $4.3B in free cash flow before working capital while oil prices fell ~14% YoY, completed the OxyChem sale to reduce principal debt to $15B, announced an 8% dividend increase, and guided 2026 capital spending to $5.5–$5.9B with production averaging ~1.45 MMboe/d.

OxyChem Divestiture & Balance Sheet 24 Capital Discipline & 2026 Plan 17 Enhanced Oil Recovery & Technology 14 Financial Performance & Free Cash Flow 13 Macro / Oil Price Outlook 9 Reserves & Resource Base 9

Management tone

Confident

Net tone +62 · low hedging

Grounding quotes
  • “2025 was an exceptional year for Oxy, made possible by the focus, discipline and commitment of our people.”
  • “the portfolio we have today is the strongest Oxy's ever had”
  • “We're still somewhat cautious about 2026 because we believe it's essential to focus on the fundamentals.”
  • “We are prepared to assume that the fundamentals do not support current price levels.”

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $4.01B +95.1% YoY
Net income · derived Q4 $114.00M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Record 2025 production of 1.434 MMboe/d exceeded the high end of guidance while spending $300M less in oil and gas capital than originally planned.
  • Generated $4.3B in free cash flow before working capital despite oil prices down ~14% from 2024; normalized cash flow from operations rose 27% YoY excluding OxyChem.
  • Reduced principal debt by $4B in 2025, completing the OxyChem sale brought debt to $15B, and a tender offer is expected to further cut debt to $14.3B.
  • Announced 8% increase to quarterly dividend to $0.26/share, with the dividend per share having doubled in the last four years.
  • Achieved 107% organic and 98% all-in reserves replacement ratio with finding and development cost below DD&A rate; 84% of total 16.5B BOE resource base breaks even below $50/bbl.
  • Cut annual operating expenses by $275M and lowered new well capital costs 15% YoY (Permian down 16%, Rockies down 13%), building on ~$2B in annual oil and gas cost savings since 2023.

Risks & pressure points

  • Q4 oil and gas pre-tax income fell to $0.7B from $1.3B in Q3 2025, driven by lower realized commodity prices across all products.
  • Q4 worldwide realized crude oil prices fell 9% QoQ to $59.22/bbl, NGL prices fell 15% to $16.68/bbl, and domestic gas prices dropped 24% to $1.12/Mcf.
  • Reported Q4 net loss attributable to common stockholders of $68M ($0.07/diluted share) due to OxyChem-related charges and transaction costs; all-in reserves replacement ratio of 98% means reserves added did not fully cover production.
  • Management remains cautious on 2026 macro, viewing recent price spikes as unsustainable and stating the situation "could be resolved quickly," while global reserve replacement ratio remains under 25%.

Key moments

Jump directly to management's words in the synchronized transcript.

“We repaid $4 billion in debt from multiple sources. And with the completion of the OxyChem sale earlier this year, our principal debt now stands at $15 billion, about $3 billion lower than before the CrownRock acquisition. Just this morning, we announced a tender offer that is expected to further reduce principal debt to $14.3 billion, reaching that target we set when we announced the OxyChem transaction.” Vicki Hollub, CEO

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Capital spending
2026
$5.5B – $5.9B

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Dividend / share
$0.26
Full-screen source Call document